Hadasit Bio Holdings (XTAE:HDST-M) ROCE %

: -110.90% (As of Dec. 2023)

View and export this data going back to 2006. Start your Free Trial

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Hadasit Bio Holdings's annualized ROCE % for the quarter that ended in Dec. 2023 was -110.90%.

Hadasit Bio Holdings ROCE % Historical Data

The historical data trend for Hadasit Bio Holdings's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hadasit Bio Holdings Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

-111.99

141.91

54.99

-60.86

-136.70

Hadasit Bio Holdings Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
ROCE %	Get a 7-Day Free Trial															12.01	-98.82	-26.37	-195.13	-110.90

Hadasit Bio Holdings ROCE % Calculation

Hadasit Bio Holdings's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	-28.996	/	( ( (38.954 - 2.467)	+	(8.065 - 2.128) )	/ 2 )
	=	-28.996	/	( (36.487	+	5.937)	/ 2 )
	=	-28.996	/	21.212
	=	-136.70 %

Hadasit Bio Holdings's ROCE % of for the quarter that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2023 )		(Q: Jun. 2023 )		(Q: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2023 )		(Q: Jun. 2023 )		(Q: Dec. 2023 )
	=	-10.214	/	( ( (14.669 - 2.185)	+	(8.065 - 2.128) )	/ 2 )
	=	-10.214	/	( ( 12.484	+	5.937 )	/ 2 )
	=	-10.214	/	9.2105
	=	-110.90 %

(1) Note: The EBIT data used here is two times the semi-annual (Dec. 2023) EBIT data.

Hadasit Bio Holdings (XTAE:HDST-M) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Hadasit Bio Holdings ROCE % Related Terms

Thank you for viewing the detailed overview of Hadasit Bio Holdings's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Hadasit Bio Holdings (XTAE:HDST-M) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Hadasit Bio Holdings Ltd (XTAE:HDST-M) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

HSITF:USA

Address

5th Floor, Jerusaelm Bio-Park, Hadassah Ein-Kerem Campus, Jerusalem, ISR, 91120

Website

http://www.hbl.co.il

Hadasit Bio Holdings Ltd serves as a precedent in the field of biotech financing. It is engaged in the advancement and enhancement of its portfolio companies. Its portfolio companies are involved in the field of medical and biotechnological research and production and distribution of the results of the research and development done in these areas.

Hadasit Bio Holdings (XTAE:HDST-M) Headlines

No Headlines